Clinical Trial Update: Anlotinib to Malignant Brainstem Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating anlotinib in malignant brain stem glioma and glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Malignant Brain Stem Tumor

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Malignant Brain Stem Tumor, Glioma | Phase 2 | Status: UNKNOWN